e-learning
resources
Milan 2017
Sunday, 10.09.2017
Best clinical practice for the management of chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion
F. Çiftci (Ankara, Turkey)
Source:
International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Session:
Best clinical practice for the management of chronic lung diseases
Session type:
Poster Discussion
Number:
365
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Çiftci (Ankara, Turkey). The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion. 365
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Correlation between pleural fluid and serum C-reactive protein in patients with pleural effusion due to different etiologies
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020
The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Role of serum and pleural fluid NT-proBNP levels in identifying pleural effusion due to heart failure
Source: Annual Congress 2008 - Pleural effusion
Year: 2008
The diagnostic value of pleural fluid C-reactive protein level in pleural effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002
Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions
Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions
Year: 2010
Pleural fluid procalcitonin levels in identifying pleural effusions due to infection
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009
Pleural fluid leptin level for the differential diagnosis of pleural effusion
Source: Eur Respir J 2006; 28: Suppl. 50, 343s
Year: 2006
Homocysteine levels in pleural effusion etiology
Source: Eur Respir J 2007; 30: Suppl. 51, 89s
Year: 2007
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010
Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions
Source: Eur Respir J 2003; 22: Suppl. 45, 60s
Year: 2003
Pleural fluid IL-6 levels in the identification of the complicated parapneumonic pleural effusion
Source: Annual Congress 2008 - Pleural effusion
Year: 2008
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Diagnostic accuracy of pleural fluid NTpro-BNP for pleural effusions of cardiac origin
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012
Comparison and relationship of cholesterol and lipoproteins of pleural effusions with serum levels of them in exudative and transudative pleural fluid
Source: Eur Respir J 2005; 26: Suppl. 49, 446s
Year: 2005
Is it important to determine pleural fluid amylase in patients with malignant pleural effusions?
Source: Eur Respir J 2007; 30: Suppl. 51, 565s
Year: 2007
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012
Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012
Pleural fluid and plasma D-dimer levels tuberculous pleurisy: the diagnostic value and relation with clinical parameters
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009
Serum C-reactive protein levels predict the need for surgical intervention in patients with empyema/complicated parapneumonic pleural effusions
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept